(Q46181656)

20 December 2017

title

alpha-Synuclein A53T substitution associated with Parkinson disease also marks the divergence of Old World and New World primates (English)

1 reference

20 December 2017

1 reference

1 reference

Bruce A Hamilton

1

1 reference

20 December 2017

publication date

1 April 2004

1 reference

20 December 2017

published in

Genomics

1 reference

20 December 2017

volume

83

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

739-742

1 reference

20 December 2017

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Neurodegenerative disease: amyloid pores from pathogenic mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

A Drosophila model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Whole-Genome Shotgun Assembly and Analysis of the Genome of Fugu rubripes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

The genome sequence of Drosophila melanogaster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

The Genome Sequence of the Malaria Mosquito Anopheles gambiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Genome sequence of the nematode C. elegans: a platform for investigating biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

The Draft Genome of Ciona intestinalis: Insights into Chordate and Vertebrate Origins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Initial sequencing and analysis of the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Inference of functional regions in proteins by quantification of evolutionary constraints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.016

10.1016/J.YGENO.2003.09.016

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

15028296

1 reference

20 December 2017